SIRONA BIOCHEM

We proudly announce the trademarking of our groundbreaking anti-aging and anti-wrinkle molecule, TFC-1326, as GlycoProteMim™. Sirona Biochem is now engaging industry experts to chart the most effective course for commercializing GlycoProteMim™... Sirona Biochem was founded in 2009 by its current Chairman and CEO, Dr. Howard Verrico. The Company's first transaction was to acquire an exclusive global license to TFChem's proprietary diabetes drug, the SGLT2 Inhibitor... Sirona Biochem is a cosmetic ingredient and drug discovery firm with a proprietary technology. Through its wholly-owned French Subsidary TFChem, the Company specialises in stabilising carbohydrate moleclues with the goal of improving efficiacy and safety.

Also known as: Sirona Biochem Corp.

Primary location: Vancouver